SciSparc signs LOI for exclusive global out-licensing of pain treatment for $6M
PremiumThe FlySciSparc signs LOI for exclusive global out-licensing of pain treatment for $6M
9d ago
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
PremiumPress Releases
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
9d ago
SciSparc Ltd. Faces Nasdaq Delisting Over Bid Price
PremiumCompany Announcements
SciSparc Ltd. Faces Nasdaq Delisting Over Bid Price
10d ago
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
PremiumPress ReleasesSciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
10d ago
SciSparc Ltd. Eyes Major Spin-Off Deal
PremiumCompany Announcements
SciSparc Ltd. Eyes Major Spin-Off Deal
18d ago
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
PremiumPress Releases
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
18d ago
SciSparc Secures Strategic Advantage with Grant of European Patent
PremiumPress ReleasesSciSparc Secures Strategic Advantage with Grant of European Patent
2M ago
Automax Motors Ltd.: Annual Financial Overview
PremiumCompany Announcements
Automax Motors Ltd.: Annual Financial Overview
3M ago
SciSparc Announces Strategic Merger with Automax Motors
PremiumCompany Announcements
SciSparc Announces Strategic Merger with Automax Motors
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100